"From New Vaccines To The Advent Of New Neurotoxins" — Lisette Hilton
It’s an extraordinary time in dermatology, said Mark Lebwohl, MD, professor and chair of dermatology at the Icahn School of Medicine at Mount Sinai and system chair of the Waldman department of dermatology for the Mount Sinai Health System. He added that today, there are treatments for conditions that didn’t have viable treatment option ten or 20 years ago. Dr. Lebwohl directed the “What’s New in Dermatology,” session on February 20th during the American Academy of Dermatology meeting in San Diego. For surgical dermatology, target treatments for advanced and metastatic non‐melanoma skin cancers have been impactful, said Desiree Ratner, MD, director of the comprehensive skin cancer center at Mount Sinai Downtown Chelsea Center. “Whatʹs new in surgical dermatology these days relates to the management of advanced non‐melanoma skin cancers, for which we really havenʹt had any options until quite recently,” said Dr. Ratner.
- Mark Lebwohl, MD, Professor, Chair, Dermatology, Icahn School of Medicine at Mount Sinai, System Chair, Waldman Department of Dermatology, Mount Sinai Health System
- Desiree Ratner, MD, Professor, Dermatology, Icahn School of Medicine at Mount Sinai, Director, The Comprehensive Skin Cancer Center, Mount Sinai Downtown